Lynn Seely's Net Worth

$36.1 Million

Estimate Recalculated Nov 4, 2024 02:36AM EST

Who is Lynn Seely

Lynn Seely has an estimated net worth of $36.1 Million. This is based on reported shares across multiple companies, which include Myovant Sciences Ltd., Blueprint Medicines Corp, Lyell Immunopharma, Inc., and MEDIVATION, INC..

SEC CIK

Lynn Seely's CIK is 0001327111

Past Insider Trading and Trends

2014 was Lynn Seely's most active year for acquiring shares with 24 total transactions. Lynn Seely's most active month to acquire stocks was the month of May. 2014 was Lynn Seely's most active year for disposing of shares, totalling 52 transactions. Lynn Seely's most active month to dispose stocks was the month of August. 2012 saw Lynn Seely paying a total of $3,597,675.00 for 262,500 shares, this is the most they've acquired in one year. In 2012 Lynn Seely cashed out on 384,955 shares for a total of $17,431,187.10, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Myovant Sciences Ltd.

Principal Executive Officer
Updated Apr 07, 2020
Form 4
59.13%
500.35K
Apr 07, 2020
2.19M
Grant
Apr 03
Form 4
330.66K
Apr 09, 2019
330.66K
Grant
Apr 05
Form 4
248.45K
Apr 18, 2018
248.45K
Grant
Apr 16
Form 4
50.00%
564.11K
Jun 02, 2017
1.69M
Grant
May 31
Form 4
400.00K
May 17, 2017
400.00K
Grant
May 15
Form 3
Oct 26, 2016
1.13M
Showing 6 results

Blueprint Medicines Corp

Investor
Updated Jun 14, 2024
Form 4
61.86%
6.81K
Jun 14, 2024
17.82K
Grant
Jun 12
Form 4
93.91%
7.90K
Jun 23, 2023
16.31K
Grant
Jun 21
Form 4
135.93%
7.90K
Jun 30, 2022
13.71K
Grant
Jun 21
Form 4
189.50%
6.75K
Jun 04, 2021
10.31K
Grant
Jun 02
Form 4
514.48%
6.75K
Jun 26, 2020
8.06K
Grant
Jun 24
Form 4
Jun 23, 2020
1.31K
Options
Jun 19
Form 4
6.19K
Jun 20, 2019
6.19K
Grant
Jun 19
Form 4
17.19%
7.50K
Jun 25, 2018
51.14K
Grant
Jun 21
Form 4
33.33%
10.91K
Jun 23, 2017
43.64K
Grant
Jun 21
Form 4
50.00%
10.91K
Jun 27, 2016
32.73K
Grant
Jun 23
Form 4
21.82K
Apr 15, 2016
21.82K
Grant
Apr 14
Form 3
Apr 15, 2016
Showing 12 results

Lyell Immunopharma, Inc.

President and CEO
Updated Feb 13, 2024
Form 4
200.00K
Feb 13, 2024
200.00K
Grant
Feb 09
Form 4
Nov 20, 2023
7.50M
Acq/Dis
Nov 16
Form 4
7.50M
Dec 19, 2022
7.50M
Grant
Dec 15
Form 4
65.00K
Jun 10, 2022
65.00K
Grant
Jun 08
Form 3
Jun 16, 2021
Showing 5 results

MEDIVATION, INC.

Chief Medical Officer
Updated Feb 18, 2015
Form 4
31.00K
Feb 18, 2015
31.00K
Grant
Feb 17
Form 4
6.03%
5.50K
Feb 11, 2015
96.69K
Grant
Feb 09
Form 4
$10.18
$318.95K
Dec 22, 2014
180.51K
Options
Dec 19
Form 4
-2.86%
-5.00K
$54.81
-$442.22K
Oct 23, 2014
169.85K
Sale
ScheduledOct 22
Form 4
-12.77%
-29.35K
$49.19
-$2.39M
Oct 17, 2014
200.51K
Sale
Oct 15 - Oct 16
Form 4
-12.67%
-55.00K
$53.95
-$4.90M
Sep 18, 2014
379.02K
Sale
ScheduledSep 17 - Sep 18
Form 4
-8.37%
-20.00K
$52.60
-$1.68M
Sep 11, 2014
219.02K
Sale
ScheduledSep 09
Form 4
-7.72%
-20.00K
$50.01
-$1.58M
Aug 28, 2014
239.02K
Sale
ScheduledAug 26 - Aug 27
Form 4
-13.89%
-20.00K
$46.01
-$1.50M
Aug 14, 2014
124.02K
Sale
ScheduledAug 13
Form 4
-21.79%
-25.50K
$46.21
-$1.88M
Aug 12, 2014
91.52K
Sale
ScheduledAug 08 - Aug 12
Form 4
-6.30%
-7.50K
$40.35
-$504.20K
Jul 23, 2014
111.52K
Sale
ScheduledJul 22
Form 4
-9.30%
-12.00K
$44.21
-$835.57K
Jul 07, 2014
117.02K
Sale
ScheduledJul 02
Form 4
-11.19%
-15.00K
$40.74
-$1.02M
Jun 19, 2014
119.02K
Sale
ScheduledJun 03 - Jun 18
Form 4
39.00K
Feb 20, 2014
39.00K
Grant
Feb 18
Form 4
13.46%
7.00K
Feb 06, 2014
59.02K
Grant
Feb 04
Form 4
45.00K
Dec 18, 2012
45.00K
Grant
Dec 17
Form 4
20.92%
9.00K
Dec 11, 2012
52.02K
Grant
Dec 07
Form 4
-34.63%
-40.00K
$67.10
-$2.60M
Jul 27, 2012
75.51K
Sale
ScheduledJul 26 - Jul 26
Form 4
-17.48%
-12.50K
$50.99
-$937.96K
May 24, 2012
59.01K
Sale
ScheduledMay 22
Form 4
-10.57%
-14.36K
$54.59
-$959.83K
May 21, 2012
121.51K
Sale
ScheduledMay 17
Form 4
-20.78%
-35.64K
$54.63
-$2.38M
May 16, 2012
135.87K
Sale
ScheduledMay 14
Form 4
-66.38%
-111.56K
$40.24
-$6.95M
Mar 12, 2012
56.51K
Sale
ScheduledMar 08
Form 4
396.62%
66.10K
Dec 13, 2011
82.77K
Grant
Dec 09
Form 4
-37.69%
-50.00K
$10.04
-$643.88K
Mar 17, 2011
82.67K
Sale
ScheduledMar 15
Form 4
-27.37%
-50.00K
$10.79
-$718.32K
Feb 16, 2011
132.67K
Sale
ScheduledFeb 15
Form 4
-21.49%
-50.00K
$9.31
-$570.95K
Jan 20, 2011
182.67K
Sale
ScheduledJan 18 - Jan 19
Form 4
66.67K
Dec 17, 2010
66.67K
Grant
Dec 15
Form 4
94.00K
Dec 17, 2009
94.00K
Grant
Dec 15
Form 4
-7.69%
-18.00K
$18.44
-$534.06K
Dec 08, 2009
216.00K
Sale
ScheduledDec 07
Form 4
-7.14%
-18.00K
$14.74
-$400.79K
Sep 11, 2009
234.00K
Sale
ScheduledSep 09 - Sep 10
Form 4
-6.67%
-18.00K
$12.99
-$337.80K
Jul 02, 2009
252.00K
Sale
ScheduledJun 30 - Jul 01
Form 4
-6.25%
-18.00K
$10.12
-$234.65K
Mar 19, 2009
270.00K
Sale
ScheduledMar 18
Form 4
-3.03%
-9.00K
$8.88
-$95.01K
Dec 05, 2008
288.00K
Sale
ScheduledDec 03
Form 4
75.00K
Nov 03, 2008
75.00K
Grant
Oct 31
Form 4
-2.94%
-9.00K
$16.59
-$233.72K
Sep 29, 2008
297.00K
Sale
ScheduledSep 25
Form 4
-2.86%
-9.00K
$9.27
-$102.03K
Jun 11, 2008
306.00K
Sale
ScheduledJun 09
Form 4
-2.78%
-9.00K
$9.62
-$108.32K
Mar 05, 2008
315.00K
Sale
ScheduledMar 03
Form 4
-2.70%
-9.00K
$8.36
-$85.55K
Dec 05, 2007
324.00K
Sale
ScheduledDec 03
Form 4
150.00K
Oct 18, 2007
483.00K
Grant
Oct 01
Form 4
-2.63%
-9.00K
$11.27
-$138.06K
Sep 21, 2007
333.00K
Sale
ScheduledSep 19
Form 4
-2.56%
-9.00K
$10.15
-$117.89K
Jun 07, 2007
342.00K
Sale
ScheduledJun 05
Form 4
-2.50%
-9.00K
$10.70
-$127.80K
Mar 20, 2007
351.00K
Sale
ScheduledMar 16
Form 3
May 18, 2005
Showing 43 results